Protective effect of methanol-methylene chloride extract of Terminalia glaucescens leaves on streptozotocin-induced diabetes in mice

Tropical Journal of Pharmaceutical Research

Volumn 8, Issue 1, 2009, Pages 19-26

  Njomen, Guy B S N ^a   Kamgang, René ^a   Soua, Petit R N ^a   Oyono, Jean L E ^a   Njikam, Njifutie ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Diabetes mellitus; Glycemia; Lipemia; Streptozotocin; Terminalia glaucescens

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; METHANOL METHYLENE CHLORIDE; PLANT EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BULIMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES CONTROL; DRUG DOSE COMPARISON; FATTY ACID BLOOD LEVEL; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PLANT LEAF; POLYDIPSIA; TERMINALIA; TERMINALIA GLAUCESCENS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 69249100164     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v8i1.14708     Document Type: Article

References (25)

1. Kameswara Rao B, Renuka Sudarshan P, Rajasekhar MD, Nagaraju N, Appa Rao Ch. Antidiabetic activity of Terminalia pallida fruit in alloxan-induced diabetic rats. J Ethnopharmacol, 2003; 85:169-172. (Pubitemid 36170070)
2. Foulis AK. The pathogenesis of □-cells destruction in type1 (insulin-dependent) diabetes mellitus. J Pathol, 1987; 152:141-148. (Pubitemid 17102763)
3. Gepts W, Le Compte PM. The pathology of type I (juvenile) diabetes, in: Body weight yolk , E.R.Arquilla (Eds), The Diabetic pancreas. Plenum N, 1985, pp337-365.
4. Takamura T, Ando H, Nagai Y, Yamashita H, Nohara E, Kobayashi K. Pioglitazone prevents mice from multiple low dose streptozotocin -induced insulitis and diabetes. Diab Res Clin Pract, 1999; 44:107-114. (Pubitemid 29447676)
5. Burcelin R, Eddouks M, Maury J, Kande J, Assan R, Girard J. Excessive glucose production, rather than insulin resistance, accounts for hyperglycemia in recent-onset streptozotocin-diabetic rats. Diabetologia, 1995; 38:283-290.
6. Kameswara B, Kesavulu MM, Apparao C. Anti-hyperglycemia activity of Momordica cymbalaria in alloxan diabetics rats. J Ethnopharmacol, 2001; 78:67-71. (Pubitemid 32913084)
7. Kamtchouing P, Kahpui SM, Djomeni Dzeufiet P-D, Tédong L, Asongalem EA, Dimo T. Anti-diabetic activity of methanol/methylene chloride stem bark extracts of Terminalia superba and Canarium schweinfurthii on streptozotocin-induced diabetic rats. J Ethnopharmacol, 2006; 104:306-309. (Pubitemid 43356640)
8. Luo J, Fort DM, Carlson TJ. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of potentially useful new antihyperglycemia agent. Diabetic Med, 1998; 15:367-374. (Pubitemid 28197103)
9. Zheng J, He J, Ji B, Li Y, Zhang X. Anti-hyperglycemia activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pac J Clin Nutr, 2007; 16(Suppl 1):427-431. (Pubitemid 46524639)
10. Mukherjee SK. Indigenous drugs in diabetes mellitus. J Diab Assoc Ind, 1981; 21:97-106
11. Nalamolu Koteswara Rao and Srinivas Nammi. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med, 2006; 6:17.
12. Rai MK. A review on some antidiabetic plants of india. Ancient Sci Life, (1995) 14:42-54.
13. Tsvia P, Barak AT, Israel S. Clioquinol attenuates zincdependent β-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in mice. Eur J Pharmacol, 2007; 565:232-239.
14. Ji-Youn Youn, Hyo-Young Park and Kyung-Hea Cho. Anti-hyperglycemic activity of Commelina communis L.: inhibition of α-glucosidase. Diab Res Clin Pract, 2004; 66(suppl.1):149-155
15. Ojewole JAO, Drewes SE. Hypoglycemia effect of Eriosema kraussianum N. E. Br. [Fabaceae] rootstock hydro-alcohol extract in rats. J Nat Med, 2007; 61:244-250.
16. Atta-ur-Rahman, Seema Zareen, Choudhary MI, Akhtar MN, Shahida Shujaat, Ngounou FN. Some chemical constituents of Terminalia glaucescens and their enzyme inhibition activity. Zeitschrift für Naturforschung. B, Chemical Sciences, 2005; 60(2):347-350.
17. Reusser F.. Mode of action of streptozotocin. J Bacteriol, 1971; 105:580-588.
18. Szkudelski T. The mechanism of alloxan and streptozotocin action in □-cells of the rat pancreas. Physiol Res, 2001; 50:536-546. (Pubitemid 34087272)
19. Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG. Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia, 1978; 15:53-57. (Pubitemid 8363626)
20. Robbins MJ, Sharp RA, Slonium AE, Burr IM. Protection against streptozotocin-induced diabetes by superoxide dismutase. Diabetologia, 1980; 18:55-58.
21. Sandler S, Andersson A. The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro. Diabetologia, 1982; 23:374-378.
22. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest, 1996; 97:2859-2865. (Pubitemid 26197099)
23. Boden G, Chen X, Iqbal N. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes, 1998; 47:1609-1612. (Pubitemid 28445349)
24. Reaven GM, Chang H, Ho H, Jeng CY, Hoffman BB. Lowering of plasma glucose in diabetic rats by antilipolitic agents. Am J Physiol, 1988; 254:E23-E30. (Pubitemid 18054423)
25. Saloranta C, Fransilla-Kallunki A, Ekstrand A, Taskinen MR, Groop L. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 1991; 34:409-415.